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Macrophage Colony-Stimulating Factor Is Required for
Human Monocyte Survival and Acts as a Cofactor for
Their Terminal Differentiation to Macrophages In Vitro
Wolfram Brugger, Marina Kreutz, and Reinhard Andreesen
Medizinische KIlnik der Albert-Ludwigs-Universitat Freiburg, Germany
Functional competence as well as phenotype heterogeneity of macrophages depend on
the completion of their maturation pathway. Differentiation of committed myeloid pro-
genitor cells is induced by colony-stimulating factors (CSF), but no consistent data exist
on which factor(s) induce the terminal maturation from the circulating blood monocyte to
the mature macrophage. In vitro, monocyte to macrophage transformation occurs in the
presence of serum and can be followed by the expression of the maturation-associated
antigens gp65-MAX.i , gp68-MAX.3, and CD51 . We describe that the differentiation-
inducing activity in serum cannot be replaced by any of the known and available purified
recombinant cytokines. In the absence of serum monocytes die in suspension cultures
while surviving as non-differentiating cells when cultured adherent to plastic. In serum-
free suspension cultures survival can be significantly improved by the addition of
recombinant human macrophage (rhM)-CSF whereas other cytokines do not. At any stage
of serum-free adherent culture, monocyte to macrophage differentiation can be induced
rapidly by the addition of serum, whereas cytokines (rhM-CSF, recombinant human
granulocyte macrophage [rhGMJ-CSF, recombinant human granulocyte [rhGJ-CSF, re
combinant human interleukin [rhlL]-i , rhlL-3, rhlL-4, rhlL-6, tumor necrosis factor [TNFJ-a,
interferon [IFN]-a, IFN-y) alone or in combination are not effective. Serum-induced
maturation, however, was suppressed in the presence of neutralizing anti-M-CSF anti-
bodies. In addition to phenotype analysis, the secretory repertoire of rhM-CSF cultured
monocytes was analyzed in comparison to serum cultured monocytes which further
characterized them to be immature cells, i.e., low release of maturation-associated
products such as a-2-macroglobulin, neopterin, fibronectin, and TNF-a, but high lL-6
secretion, an attribute of blood monocytes. We conclude that for monocyte survival in
vitro the presence of endogenous M-CSF and possibly other autocrine factors elicited by
cell adherence are required for the induction of macrophage maturation; however, yet
undefined additional factor(s) are necessary. They are present in serum and may act in
conjunction with M-CSF but are distinct from all known cytokines. Our in vitro system may
be useful in the screening and discovery of these serum factor(s).
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INTRODUCTION
Cells of the mononuclear phagocyte system (MPS)
are involved in the immune response, in host defense
against microorganisms , in control of tumor development
and spread, inflammatory reactions, regulation of he-
matopoiesis, bone formation, iron metabolism, and in the
removal of senescent cells [24,25,28,30]. Ubiquitous
distribution and phenotype variability are characteristic
attributes of this cell system consisting of resident and
inflammatory types of tissue macrophages (MAC), free
MAC in serous cavities, and a pool of circulating
precursor cells, the blood monocytes (MO). As for other
cell lineages, complete transition of a committed bone
marrow precursor cell to the mature MAC is of crucial
importance for the acquisition of full functional compe-
tence. Upon migration from the vasculature into the
various tissues and body cavities, MO undergo terminal
maturation modulated by site-specific signals. Here, the
remarkable heterogeneity within the MPS in terms of
morphology, biochemistry, function, and antigenic phe-
notype [5 , 12-i 5 , 19,3 i ] is created. While colony-stim-
ulating factors (CSF) induce proliferation of committed
bone marrow progenitor cells and their differentiation
into promonocytes and MO [26] , factors which are
responsible for the terminal maturation beyond the blood
MO stage of differentiation are not known. Migration of
blood MO into tissues seems to be a random phenomenon
in the absence of localized stimuli (e.g. , inflammation)
Received May 15, 1990; accepted September 5. 1990.
R. Andreesen is a recipient of a Heisenberg Scholarship awarded by
the Deutsche Forschungsgemeinschaft.
Reprint requests: Reinhard Andreesen, Medizinische Klinik, Hugstet-
ter Str. 55, 7800 Freiburg, Germany.
484 Brugger et al.
and no conclusive data exist to show that circulating MO
leaving the marrow are predestined for any particular
tissue. In vivo, one of the first events to induce MO
differentiation is adherence to the vascular endothelium
[1 1 ,33] and adherence itself seems to be a priming signal
for MO gene expression such as those coding for
proto-oncogenes or various growth factors including
macrophage (M)-CSF [161. Recently, M-CSF was re-
ported to induce monocyte differentiation in vitro [8] . In
vitro, serum is well known to induce MO to MAC
differentiation. The aim of this study was to investigate
the effect of adherence and whether the differentiation-
inducing capacity of serum could be replaced by any of
the various cytokines to induce terminal differentiation of
elutriation-purified human blood MO. We used a culture
system as described elsewhere [7] where this differenti-
ation step is followed by the expression of maturation-
associated antigens (e.g., MAX antigens [2] or other
differentiation markers [3] and by characteristic changes
in the secretory repertoire of cultured MO.
MATERIALS AND METHODS
MO Isolation and Culture
Mononuclear cells (MNC) were isolated from buffy
coat preparations or cytapheresis concentrates of healthy
blood donors by density gradient centrifugation over
Ficoll/Hypaque (Pharmacia, Freiburg, FRG). MO were
separated from lymphocytes by counter-current centrif-
ugal elutriation in a J6M-E Beckman centrifuge with a
standard chamber and a JE-5 rotor at 2,500 rpm and a
flow rate of 20-25 ml/min as described elsewhere [3] and
washed twice in RPM! 1640 medium (Biochrom, Berlin,
FRG) supplemented with polyvitamins, S X l0 M
2-mercaptoethanol, antibiotics, pyruvate, and non-essen-
tial amino acids. Elutriated MO were more than 95% pure
and contaminating T-lymphocytes were less than 3% as
estimated by morphology and antigenic phenotype
(CD14, CD3, CD4, CD8 expression). MO were cultured
in suspension on hydrophobic teflon foils (Biofolie 25,
Heraeus, Hanau) at 106/ml or in 96 well microtiter plates
(Greiner, NUrtingen, FRG) as adherent monolayers at
5 x i05/ml supplemented RPM! 1640 medium with or
without heat inactivated human AB-group serum for up
to 13 days. Cultures were set up with or without
recombinant interleukin human(rh)IL 1-a, rhIL-3, and rh
tumor necrosis factor (TNF)-a (Boehringer, Mannheim,
FRG), rh granulocyte macrophage (GM)-CSF, rhG-CSF,
rhIL-3 (Behringwerke, Marburg, FRG), rhM-CSF (Cetus
Corporation, Emeryville, CA), rhIL-4 and rhIL-6 (Im-
munex Corporation, Seattle, WA), rhIFN-a (Ernst Boeh-
ringer Institut, Wien, Austria), and rhIFN-’y (Thomae,
Biberach, FRG) , respectively. Neutralizing antibodies
were kindly provided by Cetus Corporation (rabbit anti-
human M-CSF), Immunex Corporation (rabbit anti-
human GM-CSF, rabbit anti-human IL-6), and by the
National Institute for Biological Standards (NBSB),
Blanche Lane, South Mimms, Potters Bar (UK) (sheep
anti-human IL-la, sheep anti-human IL-i 3).
Analysis of MO to MAC Maturation by
Immunoperoxidase Staining of Surface Antigens
MO/MAC were attached to alcian blue coated slides
and prefixed in 0.05% glutaraldehyde on ice. They were
incubated with the following mouse monoclonal antibod-
ies (mAb): anti-3-2-microglobulin (b2M) (Beckton
Dickinson, R#{246}dermark, FRG); anti-CD14 (My4;
Coulter, Krefeid, FRG); anti-gp65 (MAX. i), anti-gp68
(MAX.3), anti-gp65 (MAX. 1 1), MAX.21 (HLA-DR)
(our own laboratory); anti-CD5 1 ( 13C2 [ i 7]) and anti-
CD7 1 (OKT9; Ortho-Diagnostics, NeckargemUnd,
FRG). A peroxidase-anti-peroxidase (PAP) technique
was applied followed by postfixation with 0504 as
described [9].
Analysis of SemiquantitatiVe Antigen Expression
in the Cell-ELISA [6]
MO/MAC cultures were analyzed for antigen expres-
sion in the microtiter plates in which the cultures
originally were initiated. MAC from teflon bags were
recovered and seeded in supplemented RPM! 1640
medium in microtiter plates (i05/ml) and incubated for
30 mm before being subjected to the cell-enzyme-linked
immunoassay (ELISA). Surface antigen expression was
performed as described recently [9] . The optical density
(OD) was measured at 492 nm, corrected by the OD of
specificity controls, mean oftriplicates. Data are given as
specific OD or in some experiments as antigen expression
index (AE!) which was calculated by dividing the OD
values of the respective antigen by the OD value for b2M
expression, X 100.
Analysis of Secretory Products in
Culture Supernatants
Five X l0 MO/MAC/mI supplemented RPM! 1640
were seeded in plastic dishes and cultured for 24 h with
or without addition of 1 g/ml Sa/mone//a abortus equi
lipopolysaccharides (LPS) or 200 IU/ml rh!FN-’y, re-
spectively. Supernatants were collected and specific
ELISA techniques were used to measure the amount of
fibronectin (own development), a-2-macroglobulin (own
development), and TNF-a (T-cell Science, Hamburg,
FRG). Neopterin was measured in a radioimmunoassay
(RIA) (!BL, Hamburg, FRG), IL-6 in a bioassay using
the IL-6 dependent cell line B9 (kindly provided by Dr.
Lucien Aarden, Amsterdam, The Netherlands [32]).
Statistical Methods
The statistical significance of the data obtained was
analyzed by the Wilcoxon’s rank-sum test; a P value of
less than 0.05 was considered significant.
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RESULTS
Blood MO differentiate into cells which share many
functional criteria of mature MAC when cultured in the
presence of serum either on hydrophobic teflon foils
[7,29] or as adherent cells on plastic substrates [35]. This
MAC differentiation can be followed by morphological
criteria or changes in enzyme activities [ 18] but is more
specific and sensitive by the expression of lineage-
restricted maturation-associated antigens of the MAX
series [2] and other differentiation markers (CD51 [3]),
which are absent on circulating blood MO but are
strongly expressed on in vitro matured MAC and on some
exudate-type MAC subsets in situ [5].
Typically, human serum promoted MO to MAC trans-
formation in a dose-dependent manner as measured by
the expression of MAX. 1 and MAX.3 antigens (Fig. 1).
Without serum no cellular differentiation occurred and
maturation-associated MAX antigens could not be de-
tected. Plastic adherent cells stayed viable in serum-free
cultures for up to 10 days. Upon addition of serum, MAC
maturation could be induced rapidly at any stage of
culture as shown in Figure 2. It was a consistent
observation in repeated experiments that differentiation
was more rapid and MAX expression higher when serum
was added on day 2 or 3 as compared with cultures where
serum was added from the beginning (Fig. 2). This is at
present not understood and might be suggestive of
priming events induced during the lag phase. When MO
were cultured in suspension on hydrophobic teflon foils,
however, MO died in serum-free medium and needed
serum or defined cytokines for better survival (Fig. 3).
Only addition of rhM-CSF and to a much lesser extent
rhGM-CSF increased MO survival in serum-free suspen-
sion cultures. Recovery rates of MO cultured in 2%
AB-group serum were 41 .6 ± 15.2% whereas recovery
rates of serum-free cultured MO were always less than
3%. Recovery of rhM-CSF cultured MO, however, was
significantly higher being 14.8 ± 2.0% ofMO originally
initiated. Both rhM-CSF and rhGM-CSF, however,
could not induce MAC maturation as measured by
antigen expression (Fig. 3). Addition of neutralizing
antibodies to rhM-CSF into serum-containing cultures
(2% AB-serum) inhibited MO survival and subsequently
differentiation, whereas neutralizing antibodies to rhGM-
CSF or rhIL-6 only had marginal effects on MO survival
and differentiation (Fig. 4). This anti-M-CSF effect could
be abrogated by the addition of 500 ng/ml rhM-CSF (not
shown in detail). None of the other cytokines tested
(rh!L-la, -1, rhlL-3, rh!L-4, rhIL-6, rhG-CSF, rhIFN-a,
rh!FN-y, rhTNF-a) either alone or in combination in-
duced MAC maturation in serum-free cultures at doses of
0.5 to 500 ng/ml as measured by the expression of
maturation-associated MAX. 1 antigens (Fig. 5). They
also did not enhance MAC recovery from teflon cultures
Fig. 1. Serum induces terminal MO to MAC maturation in vitro.
Dose-dependence of the serum effect. 5 x i05 elutriation-puri-
fied MO/mi was cultured in supplemented RPMI i640 medium
for 7 days in microtiter plates at different concentrations of
human AB-group serum. Maturation-associated antigen expres-
sion was evaluated by cell-ELISA, data are given as the specific
optical density (0D492 nm) for MAX.i and MAX.3 expression.
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Fig. 2. Induction of MAC maturation upon addition of serum to
primarily serum-free cultured MO. 5 x i05 elutriation-purified
MO/mI were cultured in supplemented RPMI i640 medium in
microtiter plates for up to 1 3 days. AB-serum (2%) was added as
indicated. Cultures were subjected to phenotype analysis by
cell-ELISA on days i , 3, 5, 7, 9, or i3, respectively. AEI are shown
for MAX.1 expression. Data are given from one representative
experiment.
supplemented with suboptimal serum concentrations (not
shown in detail).
When culture-derived MO/MAC were tested for their
secretory activity, a characteristic difference was noticed
for rhM-CSF cultured MO in comparison to serum
cultured MAC (Table 1). The maturation-associated
products fibronectin and a-2-macroglobulin were se-
creted only by cells cultured in 2% AB-serum but not by
MO cultured in rhM-CSF or rhGM-CSF. MO cultured
in rhM-CSF produced neopterin and TNF-a only in
amounts comparable to blood MO, whereas MO cultured
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Fig. 3. Effect of M-CSF and GM-CSF on MAC survival and
maturation in serum-free cultures. 5 x iO elutriation-purified
MO/mI were cultured for 7 days on hydrophobic teflon foils in
supplemented RPMI i640 medium without or with 50 ng/ml
rhGM-CSF or 50 ng/ml rhM-CSF, respectively. Survival of cells
was evaluated as % cell recovery, viability of recovered cells
was more than 90% as estimated by trypan blue dye exclusion.
Maturation was measured by analysis of MAX.i expression on
single cells, data are given as percentage of positive cells. Data
are given from one representative experiment, out of three.
100
0
Fig. 4. Effect of neutralizing antibodies on MAC survival and
maturation in serum containing suspension cultures. 5 x iO
elutriation-purified MO/mI were cultured for 7 days on teflon
foils in supplemented RPMI i640 medium plus 2% AB-serum
without or with neutralizing antibodies (final dilution i :500)
directed to M-CSF, GM-CSF, or IL-6. For further details see
legend to Figure 4.
in 2% serum produced large amounts. In contrast,
secretion of IL-6 was lower in mature MO-derived MAC
whereas MO cultured in rhM-CSF produced still large
amounts of IL-6 which was comparable to the secretion
of IL-6 by peripheral blood MO (Table I).
DISCUSSION
The molecular identity of the regulatory signals
responsible for the terminal maturation of blood MO into
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Fig. 5. Induction of MO to MAC maturation in vitro: effect of
recombinant human cytokines. 5 x i05 elutriation-purified MO/
ml were cultured in supplemented RPMI 1640 medium for 7 days
in microtiter plates either with 2% AB-serum or rhG-CSF,
rhM-CSF, rhGM-CSF (all 50 ng/ml), rhlL-3, rhlL-i p, rhIL-4, rhlL-6,
rhlFN-a, rhlFN--y, or rhTNF-cs (all iOO U/mI), respectively. Pheno-
type analysis was performed by cell-ELISA, data are given as
AEI for MAX.i . Data are from one representative experiment.
MAC in vitro is yet unresolved. Up to now, the only
source for this activity is serum or plasma [1-
3,7,18,22,23]. In this study, we analyzed the effect of
cell adherence and certain cytokines in comparison to
serum on survival and maturation in primary long-term
cultures of peripheral human blood MO. Whereas serum
was shown to be essential to promote MO survival in
suspension cultures, only MO cultured adherent to plastic
were able to survive in the absence of serum. Confirming
earlier work by Becker et al. [8], M-CSF was able to
partially replace serum in suspension cultures; however,
neither M-CSF nor adherence alone was sufficient to
induce MO to mature MAC transformation as evident
from surface antigen and functional analysis. Appar-
ently, other serum factors in addition to M-CSF are
needed to induce MAC differentiation. Unlike M-CSF,
other cytokines with hematopoietic activity (IL-3, IL-6,
G-CSF, GM-CSF) did not induce MO survival and
similarily failed to induce MO differentiation. Also,
inhibition of serum-induced MAC differentiation was
seen only in the presence of neutralizing antibodies to
M-CSF. Adherence may be an essential competence
signal for MO to MAC maturation also in vivo where MO
migration is initiated by their adherence to the capillary
endothelium [1 1 ,33] . It is of interest in this respect that
adherence has been shown to induce gene expression for
several cytokines including that for M-CSF [ 16] . Own
experiments confirm these results and further demon-
strate the constitutive expression of M-CSF mRNA
during MO to MAC differentiation (manuscript in prep-
aration). In vitro, about 2 ng/106 MO per 24 h are
secreted in plastic adherent MO cultures (own unpub-
lished results, measured courtesy by Peter Ralph, Cetus
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TABLE 1 . Analysis of Se cretory Prod ucts and M aturation-Associated Antigens
MO’
Primary MAC culturesb
None 2% AB + M-CSF + GM-CSF
Functional analysis
Fibronectinc <10 <10 540 27 <10
(ng/ml)
a-2-macroglobulin <10 <10 284 28 22
(ng/ml)
Neopterind 0.16 0.24 2.72 0.29 0.33
(ng/ml)
TNfaC 1.3 <0.2 12.0 <0.2 <0.2
(ng/ml)
IL6e 1,700 1,840 680 2,090 1,800
(U/ml)
Antigen expression (AEI)
MAX.1 <5 <5 69 <5 8
MAX.3 <5 6 76 10 <5
CD51 <5 <5 52 <5 <5
aFreshly elutriated blood MO (5 X I 05/Ml) were cultured for 24 h in plastic dishes without (C) or with
addition of 1 g/ml S. abortus equi () or 200 lU/mI rhIFN-g (d), respectively. The supematants were
collected and secretory products were measured as described in Materials and Methods.
bElutriated blood MO were cultured for 7 days on hydrophobic teflon foils in supplemented RPMI
1640 medium in the absence or presence of 2% AB-serum, 50 ng/ml rhM-CSF, and 50 ng/ml
rhGM-CSF, respectively. 5 X 1 O MO/MAC/ml were cultured for 24 h without(C)or with addition of
1 j.g/ml S. abortus equi () or 200 IU/ml rhIFN-g (d), respectively for the analysis of secretory
products.
()Maturation-associated phenotype analysis was measured by cell-ELISA. Data are given as AEI. All
data are from one representative experiment, out of four.
Corp. , Emeryville). Additional autocrine factors elicited
by adherence may also be required for MO survival or,
alternatively, M-CSF may prime MO for the production
of other monokines [34], which in turn could help to
induce terminal MO maturation.
Further evidence for an important role of M-CSF in the
development of a functional competent MAC comes from
the work of Munn and Cheung [2 1 ] who described the
induction of antibody-dependent cellular cytotoxicity
(ADCC) by human blood MO cultured with M-CSF.
Their claim, however, to have induced mature MAC by
M-CSF is not substantiated by their results [21].
Thus, the question still remains: which serum-derived
factor(s) operate with M-CSF in induction of cell differ-
entiation?
Akiyama et al. [1] attempted to characterize certain
serum proteins and found human !gG, fibronectin, and
fibrinogen to induce MAC maturation. We also tested
these and other serum components but could not confirm
their results (not shown here). Te Velde et al. [27]
suggested IL-4 to be a MAC differentiation factor, an
observation which again could not be confirmed by us
(Fig. 5). It should be noticed that definition of cell
maturation is rather poor in both reports, e.g. , increased
expression of MHC class I! molecules was correlated to
MAC maturity. This, however, occurs in MO cultures
even in the absence of any proteins and, accordingly, any
evidence of MAC differentiation [3]. IFN-y rather sup-
pressed MO to MAC differentiation in our system as
shown recently [4]. This may be in line with a previous
study by Clement et al. [10] who postulated that T-
cell-derived lymphokines distinct from IFN-’y or GM-
CSF are responsible for MO differentiation.
In conclusion, we believe that M-CSF may be required
only for cell survival but not for the induction of MO to
MAC differentiation. It may activate distinct MO/MAC
functions at a defined stage of differentiation (as shown
for ADCC or monokine production), but in MO to MAC
differentiation it serves only as a competence factor
which needs additional mediator molecules. These are
present in serum or induced by serum and seem to be
distinct from all yet defined cytokines. Preliminary
evidence indicates that the active metabolite of vitamin
D3, 1 ,25-dihydroxyvitamin D3, may be a true differen-
tiation factor as it has been shown recently to induce
MAC maturation from blood MO in serum-free cultures
[20].
Our system may be useful for further analysis of
vitamin D3-induced MAC maturation and molecules with
similar activity, which should be of great importance for
the understanding of MAC physiology but which may
also be targets for new treatment strategies of immuno-
logical disorders.
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